Open Access

[Corrigendum] MicroRNA‑506‑3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis

  • Authors:
    • Liang-Kai Hu
    • Jian-Qing Chen
    • Hao Zheng
    • Yuan-Ping Tao
    • Yuan Yang
    • Xuan-Fu Xu
  • View Affiliations

  • Published online on: May 23, 2022     https://doi.org/10.3892/etm.2022.11390
  • Article Number: 463
  • Copyright : © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

July-2022
Volume 24 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hu L, Chen J, Zheng H, Tao Y, Yang Y and Xu X: [Corrigendum] MicroRNA‑506‑3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis. Exp Ther Med 24: 463, 2022
APA
Hu, L., Chen, J., Zheng, H., Tao, Y., Yang, Y., & Xu, X. (2022). [Corrigendum] MicroRNA‑506‑3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis. Experimental and Therapeutic Medicine, 24, 463. https://doi.org/10.3892/etm.2022.11390
MLA
Hu, L., Chen, J., Zheng, H., Tao, Y., Yang, Y., Xu, X."[Corrigendum] MicroRNA‑506‑3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis". Experimental and Therapeutic Medicine 24.1 (2022): 463.
Chicago
Hu, L., Chen, J., Zheng, H., Tao, Y., Yang, Y., Xu, X."[Corrigendum] MicroRNA‑506‑3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis". Experimental and Therapeutic Medicine 24, no. 1 (2022): 463. https://doi.org/10.3892/etm.2022.11390